The role of the transcription factor Miz-1 in lymphocyte development and lymphomagenesis-Binding Myc makes the difference

Seminars in Immunology

Volumn 23, Issue 5, 2011, Pages 379-387

  Möröy, Tarik ^a,b   Saba, Ingrid ^a,b   Kosan, Christian ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Apoptosis; B cell commitment; IL 7 signaling, Miz 1; T cell commitment

Indexed keywords

CD135 ANTIGEN; IMMUNOGLOBULIN M; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; JANUS KINASE; MIZ 1 TRANSCRIPTION FACTOR; MYC PROTEIN; PROTEIN BCL 2; PROTEIN BCL 6; PROTEIN P15; PROTEIN P21; PROTEIN P53; STAT5 PROTEIN; STRESS ACTIVATED PROTEIN KINASE 1; SUPPRESSOR OF CYTOKINE SIGNALING 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; B LYMPHOCYTE; BINDING AFFINITY; BONE MARROW; CARCINOGENESIS; CELL ADHESION; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL LINEAGE; CELL MATURATION; CELL SURVIVAL; CYTOPLASM; DIMERIZATION; DNA BINDING; DNA DAMAGE; ENZYME INHIBITION; GENE EXPRESSION; GENE REPRESSION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; LARGE CELL LYMPHOMA; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN MULTIMERIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMUS; UPREGULATION;

B-LYMPHOCYTES; DNA-BINDING PROTEINS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LYMPHOMA; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

EID: 82555169647     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2011.09.001     Document Type: Review

References (100)

1. Zhu J., Emerson S.G. Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene 2002, 21:3295-3313.
2. Thomas M.C., Chiang C.M. The general transcription machinery and general cofactors. Crit Rev Biochem Mol Biol 2006, 41:105-178.
3. Hecker M., Lambeck S., Toepfer S., van Someren E., Guthke R. Gene regulatory network inference: data integration in dynamic models-a review. Biosystems 2009, 96:86-103.
4. Adhikary S., Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 2005, 6:635-645.
5. Grandori C., Cowley S.M., James L.P., Eisenman R.N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 2000, 16:653-699.
6. Eilers M., Eisenman R.N. Myc's broad reach. Genes Dev 2008, 22:2755-2766.
7. Herold S., Wanzel M., Beuger V., Frohme C., Beul D., Hillukkala T., et al. Negative regulation of the mammalian UV response by Myc through association with Miz-1. Mol Cell 2002, 10:509-521.
8. Seoane J., Le H.V., Massague J. Myc suppression of the p21 (Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 2002, 419:729-734.
9. Seoane J., Pouponnot C., Staller P., Schader M., Eilers M., Massague J. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat Cell Biol 2001, 3:400-408.
10. Staller P., Peukert K., Kiermaier A., Seoane J., Lukas J., Karsunky H., et al. Repression of p15INK4b expression by Myc through association with Miz-1. Nat Cell Biol 2001, 3:392-399.
11. Peukert K., Staller P., Schneider A., Carmichael G., Hanel F., Eilers M. An alternative pathway for gene regulation by Myc. EMBO J 1997, 16:5672-5686.
12. Wanzel M., Russ A.C., Kleine-Kohlbrecher D., Colombo E., Pelicci P.G., Eilers M. A ribosomal protein L23-nucleophosmin circuit coordinates Mizl function with cell growth. Nat Cell Biol 2008, 10:1051-1061.
13. Basu S., Liu Q., Qiu Y., Dong F. Gfi-1 represses CDKN2B encoding p15INK4B through interaction with Miz-1. Proc Natl Acad Sci U S A 2009, 106:1433-1438.
14. Phan R.T., Saito M., Basso K., Niu H., Dalla-Favera R. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat Immunol 2005, 6:1054-1060.
15. Kelly K.F., Daniel J.M. POZ for effect-POZ-ZF transcription factors in cancer and development. Trends Cell Biol 2006, 16:578-587.
16. Adhikary S., Peukert K., Karsunky H., Beuger V., Lutz W., Elsasser H.P., et al. Miz1 is required for early embryonic development during gastrulation. Mol Cell Biol 2003, 23:7648-7657.
17. Kosan C., Saba I., Godmann M., Herold S., Herkert B., Eilers M., et al. Transcription factor miz-1 is required to regulate interleukin-7 receptor signaling at early commitment stages of B cell differentiation. Immunity 2010, 33:917-928.
18. Ahmad K.F., Engel C.K., Prive G.G. Crystal structure of the BTB domain from PLZF. Proc Natl Acad Sci U S A 1998, 95:12123-12128.
19. Bardwell V.J., Treisman R. The POZ domain: a conserved protein-protein interaction motif. Genes Dev 1994, 8:1664-1677.
20. Zollman S., Godt D., Prive G.G., Couderc J.L., Laski F.A. The BTB domain, found primarily in zinc finger proteins, defines an evolutionarily conserved family that includes several developmentally regulated genes in Drosophila. Proc Natl Acad Sci U S A 1994, 91:10717-10721.
21. Stead M.A., Trinh C.H., Garnett J.A., Carr S.B., Baron A.J., Edwards T.A., et al. A beta-sheet interaction interface directs the tetramerisation of the Miz-1 POZ domain. J Mol Biol 2007, 373:820-826.
22. Deweindt C., Albagli O., Bernardin F., Dhordain P., Quief S., Lantoine D., et al. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain. Cell Growth Differ 1995, 6:1495-1503.
23. Wong C.W., Privalsky M.L. Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6. J Biol Chem 1998, 273:27695-27702.
24. Huynh K.D., Bardwell V.J. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT. Oncogene 1998, 17:2473-2484.
25. Gebhardt A., Frye M., Herold S., Benitah S.A., Braun K., Samans B., et al. Myc regulates keratinocyte adhesion and differentiation via complex formation with Miz1. J Cell Biol 2006, 172:139-149.
26. Patel J.H., McMahon S.B. Targeting of Miz-1 is essential for Myc-mediated apoptosis. J Biol Chem 2006, 281:3283-3289.
27. Wu S., Cetinkaya C., Munoz-Alonso M.J., von der Lehr N., Bahram F., Beuger V., et al. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 2003, 22:351-360.
28. Patel J.H., McMahon S.B. BCL2 is a downstream effector of MIZ-1 essential for blocking c-MYC-induced apoptosis. J Biol Chem 2007, 282:5-13.
29. Saba I., Kosan C., Vassen L., Moroy T. IL-7R-dependent survival and differentiation of early T-lineage progenitors is regulated by the BTB/POZ domain transcription factor Miz-1. Blood 2011, 117:3370-3381.
30. Saito M., Novak U., Piovan E., Basso K., Sumazin P., Schneider C., et al. BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. Proc Natl Acad Sci U S A 2009, 106:11294-11299.
31. Miao L., Song Z., Jin L., Zhu Y.M., Wen L.P., Wu M. ARF antagonizes the ability of Miz-1 to inhibit p53-mediated transactivation. Oncogene 2010, 29:711-722.
32. Herkert B., Dwertmann A., Herold S., Abed M., Naud J.F., Finkernagel F., et al. The Arf tumor suppressor protein inhibits Miz1 to suppress cell adhesion and induce apoptosis. J Cell Biol 2010, 188:905-918.
33. Liu J., Zhao Y., Eilers M., Lin A. Miz1 is a signal- and pathway-specific modulator or regulator (SMOR) that suppresses TNF-alpha-induced JNK1 activation. Proc Natl Acad Sci U S A 2009, 106:18279-18284.
34. Sitnicka E., Brakebusch C., Martensson I.L., Svensson M., Agace W.W., Sigvardsson M., et al. Complementary signaling through flt3 and interleukin-7 receptor alpha is indispensable for fetal and adult B cell genesis. J Exp Med 2003, 198:1495-1506.
35. Adolfsson J., Borge O.J., Bryder D., Theilgaard-Monch K., Astrand-Grundstrom I., Sitnicka E., et al. Upregulation of Flt3 expression within the bone marrow Lin(-)Sca1(+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 2001, 15:659-669.
36. Adolfsson J., Mansson R., Buza-Vidas N., Hultquist A., Liuba K., Jensen C.T., et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 2005, 121:295-306.
37. Mansson R., Hultquist A., Luc S., Yang L., Anderson K., Kharazi S., et al. Molecular evidence for hierarchical transcriptional lineage priming in fetal and adult stem cells and multipotent progenitors. Immunity 2007, 26:407-419.
38. Medina K.L., Singh H. Genetic networks that regulate B lymphopoiesis. Curr Opin Hematol 2005, 12:203-209.
39. Kikuchi K., Lai A.Y., Hsu C.L., Kondo M. IL-7 receptor signaling is necessary for stage transition in adult B cell development through up-regulation of EBF. J Exp Med 2005, 201:1197-1203.
40. Kondo M., Akashi K., Domen J., Sugamura K., Weissman I.L. Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common gamma chain-deficient mice. Immunity 1997, 7:155-162.
41. Malin S., McManus S., Cobaleda C., Novatchkova M., Delogu A., Bouillet P., et al. Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development. Nat Immunol 2010, 11:171-179.
42. Khaled A.R., Durum S.K. Lymphocide: cytokines and the control of lymphoid homeostasis. Nat Rev Immunol 2002, 2:817-830.
43. Jiang Q., Li W.Q., Aiello F.B., Mazzucchelli R., Asefa B., Khaled A.R., et al. Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev 2005, 16:513-533.
44. Kovanen P.E., Leonard W.J. Cytokines and immunodeficiency diseases: critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol Rev 2004, 202:67-83.
45. Marshall A.J., Fleming H.E., Wu G.E., Paige C.J. Modulation of the IL-7 dose-response threshold during pro-B cell differentiation is dependent on pre-B cell receptor expression. J Immunol 1998, 161:6038-6045.
46. Trigueros C., Hozumi K., Silva-Santos B., Bruno L., Hayday A.C., Owen M.J., et al. Pre-TCR signaling regulates IL-7 receptor alpha expression promoting thymocyte survival at the transition from the double-negative to double-positive stage. Eur J Immunol 2003, 33:1968-1977.
47. Ram P.A., Waxman D.J. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J Biol Chem 1999, 274:35553-35561.
48. Alexander W.S., Starr R., Metcalf D., Nicholson S.E., Farley A., Elefanty A.G., et al. Suppressors of cytokine signaling (SOCS): negative regulators of signal transduction. J Leukoc Biol 1999, 66:588-592.
49. Hilton D.J. Negative regulators of cytokine signal transduction. Cell Mol Life Sci 1999, 55:1568-1577.
50. Yasukawa H., Sasaki A., Yoshimura A. Negative regulation of cytokine signaling pathways. Annu Rev Immunol 2000, 18:143-164.
51. Carvalho T.L., Mota-Santos T., Cumano A., Demengeot J., Vieira P. Arrested B lymphopoiesis and persistence of activated B cells in adult interleukin 7(-/-) mice. J Exp Med 2001, 194:1141-1150.
52. Hesslein D.G., Yang S.Y., Schatz D.G. Origins of peripheral B cells in IL-7 receptor-deficient mice. Mol Immunol 2006, 43:326-334.
53. Miller J.P., Izon D., DeMuth W., Gerstein R., Bhandoola A., Allman D. The earliest step in B lineage differentiation from common lymphoid progenitors is critically dependent upon interleukin 7. J Exp Med 2002, 196:705-711.
54. Fridman J.S., Lowe S.W. Control of apoptosis by p53. Oncogene 2003, 22:9030-9040.
55. Rajewsky K. Clonal selection and learning in the antibody system. Nature 1996, 381:751-758.
56. Dent A.L., Shaffer A.L., Yu X., Allman D., Staudt L.M. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 1997, 276:589-592.
57. Fukuda T., Yoshida T., Okada S., Hatano M., Miki T., Ishibashi K., et al. Disruption of the Bcl6 gene results in an impaired germinal center formation. J Exp Med 1997, 186:439-448.
58. Ye B.H., Cattoretti G., Shen Q., Zhang J., Hawe N., de Waard R., et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 1997, 16:161-170.
59. Phan R.T., Dalla-Favera R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 2004, 432:635-639.
60. Boehm T., Bleul C.C. Thymus-homing precursors and the thymic microenvironment. Trends Immunol 2006, 27:477-484.
61. Benz C., Martins V.C., Radtke F., Bleul C.C. The stream of precursors that colonizes the thymus proceeds selectively through the early T lineage precursor stage of T cell development. J Exp Med 2008, 205:1187-1199.
62. Schwarz B.A., Sambandam A., Maillard I., Harman B.C., Love P.E., Bhandoola A. Selective thymus settling regulated by cytokine and chemokine receptors. J Immunol 2007, 178:2008-2017.
63. Allman D., Sambandam A., Kim S., Miller J.P., Pagan A., Well D., et al. Thymopoiesis independent of common lymphoid progenitors. Nat Immunol 2003, 4:168-174.
64. Bleul C.C., Corbeaux T., Reuter A., Fisch P., Monting J.S., Boehm T. Formation of a functional thymus initiated by a postnatal epithelial progenitor cell. Nature 2006, 441:992-996.
65. Lai A.Y., Kondo M. Asymmetrical lymphoid and myeloid lineage commitment in multipotent hematopoietic progenitors. J Exp Med 2006, 203:1867-1873.
66. Lai A.Y., Kondo M. Identification of a bone marrow precursor of the earliest thymocytes in adult mouse. Proc Natl Acad Sci U S A 2007, 104:6311-6316.
67. Lai A.Y., Lin S.M., Kondo M. Heterogeneity of Flt3-expressing multipotent progenitors in mouse bone marrow. J Immunol 2005, 175:5016-5023.
68. Porritt H.E., Rumfelt L.L., Tabrizifard S., Schmitt T.M., Zuniga-Pflucker J.C., Petrie H.T. Heterogeneity among DN1 prothymocytes reveals multiple progenitors with different capacities to generate T cell and non-T cell lineages. Immunity 2004, 20:735-745.
69. Hoffman E.S., Passoni L., Crompton T., Leu T.M., Schatz D.G., Koff A., et al. Productive T-cell receptor beta-chain gene rearrangement: coincident regulation of cell cycle and clonality during development in vivo. Genes Dev 1996, 10:948-962.
70. Taghon T., Yui M.A., Pant R., Diamond R.A., Rothenberg E.V. Developmental and molecular characterization of emerging beta- and gammadelta-selected pre-T cells in the adult mouse thymus. Immunity 2006, 24:53-64.
71. Singer A., Adoro S., Park J.H. Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice. Nat Rev Immunol 2008, 8:788-801.
72. Petrie H.T., Zuniga-Pflucker J.C. Zoned out: functional mapping of stromal signaling microenvironments in the thymus. Annu Rev Immunol 2007, 25:649-679.
73. Besseyrias V., Fiorini E., Strobl L.J., Zimber-Strobl U., Dumortier A., Koch U., et al. Hierarchy of Notch-Delta interactions promoting T cell lineage commitment and maturation. J Exp Med 2007, 204:331-343.
74. Maillard I., Fang T., Pear W.S. Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annu Rev Immunol 2005, 23:945-974.
75. Radtke F., Wilson A., Stark G., Bauer M., van Meerwijk J., MacDonald H.R., et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 1999, 10:547-558.
76. Rothenberg E.V. Negotiation of the T lineage fate decision by transcription-factor interplay and microenvironmental signals. Immunity 2007, 26:690-702.
77. Banwell C.M., Partington K.M., Jenkinson E.J., Anderson G. Studies on the role of IL-7 presentation by mesenchymal fibroblasts during early thymocyte development. Eur J Immunol 2000, 30:2125-2129.
78. Bolotin E., Smogorzewska M., Smith S., Widmer M., Weinberg K. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 1996, 88:1887-1894.
79. Massa S., Balciunaite G., Ceredig R., Rolink A.G. Critical role for c-kit (CD117) in T cell lineage commitment and early thymocyte development in vitro. Eur J Immunol 2006, 36:526-532.
80. Rothenberg E.V., Moore J.E., Yui M.A. Launching the T-cell-lineage developmental programme. Nat Rev Immunol 2008, 8:9-21.
81. Akashi K., Kondo M., von Freeden-Jeffry U., Murray R., Weissman I.L. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 1997, 89:1033-1041.
82. He Y.W., Nakajima H., Leonard W.J., Adkins B., Malek T.R. The common gamma-chain of cytokine receptors regulates intrathymic T cell development at multiple stages. J Immunol 1997, 158:2592-2599.
83. Maraskovsky E., O'Reilly L.A., Teepe M., Corcoran L.M., Peschon J.J., Strasser A. Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/- mice. Cell 1997, 89:1011-1019.
84. Moore T.A., von Freeden-Jeffry U., Murray R., Zlotnik A. Inhibition of gamma delta T cell development and early thymocyte maturation in IL-7-/- mice. J Immunol 1996, 157:2366-2373.
85. von Freeden-Jeffry U., Solvason N., Howard M., Murray R. The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity 1997, 7:147-154.
86. Kang J., Coles M., Raulet D.H. Defective development of gamma/delta T cells in interleukin 7 receptor-deficient mice is due to impaired expression of T cell receptor gamma genes. J Exp Med 1999, 190:973-982.
87. Muegge K., Vila M.P., Durum S.K. Interleukin-7: a cofactor for V(D)J rearrangement of the T cell receptor beta gene. Science 1993, 261:93-95.
88. Peschon J.J., Morrissey P.J., Grabstein K.H., Ramsdell F.J., Maraskovsky E., Gliniak B.C., et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994, 180:1955-1960.
89. Schlenner S.M., Madan V., Busch K., Tietz A., Laufle C., Costa C., et al. Fate mapping reveals separate origins of T cells and myeloid lineages in the thymus. Immunity 2010, 32:426-436.
90. Hoffman B., Amanullah A., Shafarenko M., Liebermann D.A. The proto-oncogene c-myc in hematopoietic development and leukemogenesis. Oncogene 2002, 21:3414-3421.
91. Nilsson J.A., Cleveland J.L. Myc pathways provoking cell suicide and cancer. Oncogene 2003, 22:9007-9021.
92. Wade M., Wahl G.M. c-Myc, genome instability, and tumorigenesis: the devil is in the details. Curr Top Microbiol Immunol 2006, 302:169-203.
93. Baron B.W., Nucifora G., McCabe N., Espinosa R., Le Beau M.M., McKeithan T.W. Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas. Proc Natl Acad Sci U S A 1993, 90:5262-5266.
94. Basso K., Dalla-Favera R. BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis. Adv Immunol 2010, 105:193-210.
95. Lo Coco F., Ye B.H., Lista F., Corradini P., Offit K., Knowles D.M., et al. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood 1994, 83:1757-1759.
96. Pasqualucci L., Migliazza A., Basso K., Houldsworth J., Chaganti R.S., Dalla-Favera R. Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. Blood 2003, 101:2914-2923.
97. Ye B.H., Chaganti S., Chang C.C., Niu H., Corradini P., Chaganti R.S., et al. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. EMBO J 1995, 14:6209-6217.
98. Ye B.H., Lista F., Lo Coco F., Knowles D.M., Offit K., Chaganti R.S., et al. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 1993, 262:747-750.
99. Ye B.H., Rao P.H., Chaganti R.S., Dalla-Favera R. Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. Cancer Res 1993, 53:2732-2735.
100. van Riggelen J., Muller J., Otto T., Beuger V., Yetil A., Choi P.S., et al. The interaction between Myc and Miz1 is required to antagonize TGFbeta-dependent autocrine signaling during lymphoma formation and maintenance. Genes Dev 2010, 24:1281-1294.